| 000 | 01113 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250515090338.0 | ||
| 264 | 0 | _c20080115 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0144-3615 | ||
| 024 | 7 |
_a10.1080/01443610701469941 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHirose, T G | |
| 245 | 0 | 0 |
_aThe safety of RhIG in the prevention of haemolytic disease of the newborn. _h[electronic resource] |
| 260 |
_bJournal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology _cAug 2007 |
||
| 300 |
_a545-57 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aErythroblastosis, Fetal _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRh-Hr Blood-Group System _ximmunology |
| 650 | 0 | 4 |
_aRho(D) Immune Globulin _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMays, D A | |
| 773 | 0 |
_tJournal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology _gvol. 27 _gno. 6 _gp. 545-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/01443610701469941 _zAvailable from publisher's website |
| 999 |
_c17418725 _d17418725 |
||